Growth Metrics

Arcadia Biosciences (RKDA) Shares Outstanding (Weighted Average) (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Shares Outstanding (Weighted Average) readings, the most recent being $192611.0 for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 85.87% to $192611.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $192611.0, a 85.87% decrease, with the full-year FY2025 number at $192611.0, down 85.87% from a year prior.
  • Shares Outstanding (Weighted Average) hit $192611.0 in Q4 2025 for Arcadia Biosciences, down from $1.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $21.7 million in Q2 2021 to a low of $192611.0 in Q4 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $1.4 million (2024), compared with a mean of $5.1 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 97.21% in 2022 and later surged 298.68% in 2024.
  • Arcadia Biosciences' Shares Outstanding (Weighted Average) stood at $287757.0 in 2021, then increased by 19.05% to $342570.0 in 2022, then fell by 0.18% to $341957.0 in 2023, then surged by 298.68% to $1.4 million in 2024, then plummeted by 85.87% to $192611.0 in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $192611.0 (Q4 2025), $1.4 million (Q3 2025), and $195885.0 (Q2 2025) per Business Quant data.